[Retracted] Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach

<div>The prognostic value of TYK2 in pan-cancer and TCGA_HNSC. (a) The survival map showing the association between TYK2 and overall survival of pan-cancer. (b) The survival map showing the association between TYK2 and relapse-free survival of pan-cancer. (c–e) The prognostic values of TYK2 in TCGA_HNSC from the aspect of three types of prognostic parameters (i.e., overall survival (c), disease-specific survival (d), and progress-free interval (e)).</div>

Disease Markers

fig5

Figure 5

Figure 5: [Retracted] Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach 

Figure 5 | [Retracted] Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach 